| __timestamp | Gilead Sciences, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 3788000000 | 117418000 |
| Thursday, January 1, 2015 | 4006000000 | 102526000 |
| Friday, January 1, 2016 | 4261000000 | 105386000 |
| Sunday, January 1, 2017 | 4371000000 | 110188000 |
| Monday, January 1, 2018 | 4853000000 | 121544000 |
| Tuesday, January 1, 2019 | 4675000000 | 127930000 |
| Wednesday, January 1, 2020 | 4572000000 | 148917000 |
| Friday, January 1, 2021 | 6601000000 | 440760000 |
| Saturday, January 1, 2022 | 5657000000 | 540517000 |
| Sunday, January 1, 2023 | 6498000000 | 435577000 |
| Monday, January 1, 2024 | 28675800000 |
Infusing magic into the data realm
In the competitive landscape of biopharmaceuticals, Gilead Sciences, Inc. and Jazz Pharmaceuticals plc have showcased distinct trajectories in their cost of revenue over the past decade. From 2014 to 2023, Gilead Sciences has consistently maintained a higher cost of revenue, peaking in 2021 with a staggering 6.6 billion USD. This represents a 74% increase from its 2014 figures. In contrast, Jazz Pharmaceuticals, while significantly smaller in scale, has demonstrated a steady growth, with its cost of revenue increasing by approximately 270% over the same period, reaching its zenith in 2022.
This comparison not only highlights the scale at which Gilead operates but also underscores Jazz's impressive growth trajectory. As the biopharma industry continues to evolve, these financial metrics provide a window into the strategic priorities and operational efficiencies of these two industry leaders.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Jazz Pharmaceuticals plc
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Gilead Sciences, Inc.
Cost of Revenue: Key Insights for Gilead Sciences, Inc. and Telix Pharmaceuticals Limited
Analyzing Cost of Revenue: Gilead Sciences, Inc. and Ionis Pharmaceuticals, Inc.
Gilead Sciences, Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs HUTCHMED (China) Limited
Cost of Revenue Comparison: Gilead Sciences, Inc. vs Mesoblast Limited
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Jazz Pharmaceuticals plc
Cost of Revenue: Key Insights for Viatris Inc. and Jazz Pharmaceuticals plc
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Cytokinetics, Incorporated
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs ACADIA Pharmaceuticals Inc.
Jazz Pharmaceuticals plc vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored